Results 151 to 160 of about 2,423 (198)

PA200 modulates immunoproteasome structure and activity. [PDF]

open access: yesNat Commun
Živković D   +20 more
europepmc   +1 more source

Immunoproteasome deficiency results in age-dependent development of epilepsy. [PDF]

open access: yesBrain Commun
Leister H   +19 more
europepmc   +1 more source

Immunoproteasomal Inhibition With ONX-0914 Attenuates Atherosclerosis and Reduces White Adipose Tissue Mass and Metabolic Syndrome in Mice. [PDF]

open access: yesArterioscler Thromb Vasc Biol
Schaftenaar FH   +17 more
europepmc   +1 more source

Inhibition and Deficiency of the Immunoproteasome Subunit LMP7 Attenuates LCMV-Induced Meningitis [PDF]

open access: yesEuropean Journal of Immunology, 2016
In addition to antigen processing, immunoproteasomes were recently shown to exert functions influencing cytokine production by monocytes and T cells, T-helper cell differentiation, and T-cell survival.
Marcus Gröttrup   +2 more
exaly   +8 more sources

Immunohistochemical Identification and Assessment of the Location of Immunoproteasome Subunits LMP2 and LMP7 in Acquired Cholesteatoma

open access: yesInternational Journal of Molecular Sciences, 2023
Cholesteatoma, accompanied by chronic inflammatory response, is characterized by invasive growth and osteolytic activity. As specific proteasome isoforms, the immunoproteasomes serve as an important modulator of inflammatory responses.
Ewa Olszewska   +2 more
exaly   +4 more sources
Some of the next articles are maybe not open access.

Related searches:

LMP7 Inhibits the Activation of NLRP3 Inflammasome Through Interaction With NLRP3

Biochemical and Biophysical Research Communications, 2020
The innate immune system recognizes pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) by coding pattern recognition receptors (PRRs). As a well-known inflammasome, NLRP3 plays an essential role in helping the host immune response and driving antiviral processes.
Kailang Wu, Jing Jin, Aixin Li
exaly   +3 more sources

Home - About - Disclaimer - Privacy